In summary, this investigation provides novel insight into a hepatoprotective pathway whereby miR-29a inhibits GSK3β to repress SIRT1-mediated mitochondrial biogenesis, leading to alleviation of mitochondrial proteostatic stress and UPRmt in the context of MCD diet-induced NASH. The gene discussed is GSK3B; the disease is metabolic dysfunction-associated steatohepatitis.